Search
Life Sciences Regulatory Overview In this episode, we explore the complex regulatory landscape of the life sciences industry, providing attorneys with critical insights into the compliance requirements that govern pharmaceuticals, medical devices, and diagnostics. Whether you advise biotech startups...
Life Sciences Industry Basics This episode provides attorneys with a comprehensive foundation in the life sciences industry, equipping legal professionals with the knowledge needed to navigate this complex and highly regulated sector. Whether you advise pharmaceutical companies, biotech startups, or...
Saul Ewing's Intellectual Property attorneys hosted a half-day virtual conference that addressed the following trends and challenges affecting businesses and innovators nationwide: Learning how to combat brand impersonation and cyber fraud with legal tools, cybersecurity measures, and cross-industry...
Medical practices, dental practices and other health care entities must again comply with the federal Corporate Transparency Act (“CTA”). The deadline for compliance is March 21, 2025. What You Need to Know: The Corporate Transparency Act filing deadline is now March 21, 2025. Medical practices and...
Saul Ewing LLP's Consumer Financial Services Litigation Practice hosted their annual CLE program on Thursday, December 12. This program provided updates on consumer financial services civil litigation and government enforcement trends, including federal and state governments' top consumer protection...
On October 7, 2024, the New Jersey Board of Public Utilities (the “Board”) issued a Notice of Proposed Substantial Changes to its previously proposed Community Solar Energy Program regulations (the “Proposed Changes”). The notice addresses prior comments and issues changes to the Board’s September...
BALTIMORE, (JUNE 12, 2024) – In joining Saul Ewing as a new partner, Carville B. Collins brings the firm’s clients more than 30 years of experience representing energy, water and other regulated businesses seeking a wide array of approvals from Maryland regulators. His practice also includes work in...
Understanding the complex intersection of environmental regulations intended to combat climate change between now and 2050 while responding to the U.S. tech economy’s exponential growth in energy demand will require collaboration between consumers, industry and government, and reliance upon a...
“PFAS” is an acronym for per- and polyfluoroalkyl substances, a family of thousands of widely used manmade chemicals that resist grease, oil, water and heat. PFAS has been used in firefighting foams, protective coatings and stain-resistant garments and carpets. PFAS are mobile and persistent; they...
Saul Ewing LLP's Consumer Financial Services Litigation Practice recently hosted their annual half-day CLE program on Thursday, December 14. This program provided updates on consumer financial services litigation and enforcement trends, including federal and state governments' top consumer...
PCI, in partnership with Penn Medicine, is pleased to co-host a commercialization speaker series geared toward Penn Medicine faculty, researchers and students. Each session will feature an expert guest speaker as well as time for questions and discussion. The first session will discuss the latest...
Charles M. Lizza and Sarah A. Sullivan of Saul Ewing’s Newark Office secured a precedent-setting victory in a patent infringement case in the Federal District Court for the District of New Jersey involving Janssen Pharmaceuticals, Inc.’s (“J&J”) and Mitsubishi Tanabe Pharma Corp.’s (“MTPC”)...
Publication: American Bar Association ABA Business Law Section December 2018 The Business Law Section of the American Bar Association has published a 2018 supplement to The Law of Truth in Lending, a 1700-page treatise published in 2014, co-edited by Saul Ewing of Counsel John Ropiequet. The 900...
With the rise of remote work, artificial intelligence, and the Internet of Things, data centers have become a critical piece of the digital economy. These facilities require reliable, high-quality electrical power, efficient cooling systems, robust physical and cybersecurity measures, and scalable...
When allegations of research fraud or misconduct come to light, the stakes for companies and research institutions could not be higher. Actions such as fabrication of scientific data, manipulation of research materials, and plagiarism can result in damaged reputations, loss of federal funding, and...
Justin Beyer brings more than 20 years of experience to his work as a litigator focusing on disputes involving trade secrets and non-compete agreements. This includes representing companies who need to protect or reacquire misappropriated information or wish to hire a competitor's former employee...
Steven Reingold represents companies and their owners, executives, directors, and officers in complex disputes involving a wide variety of different industries. Drawing on decades of experience as a litigator in cases across the country, Steven handles claims involving contracts and loan documents...
Ian Mahany-Horton helps corporate clients protect their intellectual property through drafting and prosecuting patent applications and advising them on patent portfolio strategies for their innovations. Ian has experience working on patent matters for mechanical, electrical, and software...
Irfan Malani litigates intellectual property disputes, including matters involving patents, trademarks, and trade secrets. His experience includes cases covering a wide array of technologies and industries, from telecommunications and medical devices to cybersecurity. In addition to representing...